FierceBiotech· @FierceBiotech · X·· 29 天前精选AI 评分75
AI 导读
罗氏与中国翰森制药达成新的ADC授权交易,里程碑总额最高达15亿美元,这是双方在首次合作约一年后的再度联手。交易具体首付款与靶点信息未在材料中披露。
推荐理由
罗氏一年内二度牵手翰森,15亿美元里程碑的ADC交易规模可作观察中国ADC出海定价的参照。
正文
Roche is doubling down on China's Hansoh Pharma with a new ADC deal worth up to $15 billion in milestones. The pact comes just a year after the companies' first collaboration. https://www.fiercebiotech.com/biotech/roche-returns-chinas-adc-powerhouse-hansoh-15b-biobucks-pact $ROCH.NE
来源:FierceBiotech · x.com